[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-bis[(2-aminoacetyl)oxy]-10,13-dimethyl-17-[(1R)-1-methyl-4-oxo-4-[[1-[5-[4-[[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-tris[(2-aminoacetyl)oxy]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]methyl]triazol-1-yl]pentyl]triazol-4-yl]methylamino]butyl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]2-aminoacetate hexahydrochloride

ID: ALA5172056

Chembl Id: CHEMBL5172056

PubChem CID: 168270810

Max Phase: Preclinical

Molecular Formula: C71H120Cl6N14O14

Molecular Weight: 1387.78

Names and Identifiers

Canonical SMILES:  C[C@H](CCC(=O)NCc1cn(CCCCCn2cc(CNC(=O)CC[C@@H](C)[C@H]3CC[C@H]4[C@@H]5[C@H](OC(=O)CN)C[C@@H]6C[C@H](OC(=O)CN)CC[C@]6(C)[C@H]5C[C@H](OC(=O)CN)[C@]34C)nn2)nn1)[C@H]1CC[C@H]2[C@@H]3[C@H](OC(=O)CN)C[C@@H]4C[C@H](OC(=O)CN)CC[C@]4(C)[C@H]3C[C@H](OC(=O)CN)[C@]12C.Cl.Cl.Cl.Cl.Cl.Cl

Standard InChI:  InChI=1S/C71H114N14O14.6ClH/c1-40(48-12-14-50-66-52(28-56(70(48,50)5)98-64(92)34-76)68(3)20-18-46(94-60(88)30-72)24-42(68)26-54(66)96-62(90)32-74)10-16-58(86)78-36-44-38-84(82-80-44)22-8-7-9-23-85-39-45(81-83-85)37-79-59(87)17-11-41(2)49-13-15-51-67-53(29-57(71(49,51)6)99-65(93)35-77)69(4)21-19-47(95-61(89)31-73)25-43(69)27-55(67)97-63(91)33-75;;;;;;/h38-43,46-57,66-67H,7-37,72-77H2,1-6H3,(H,78,86)(H,79,87);6*1H/t40-,41-,42+,43+,46-,47-,48-,49-,50+,51+,52+,53+,54-,55-,56+,57+,66+,67+,68+,69+,70-,71-;;;;;;/m1....../s1

Standard InChI Key:  LXCNOLTYBJGLJP-HERNTDICSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 1387.78

Molecular Weight (Monoisotopic): 1386.8639

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Saini V, Mehta D, Gupta S, Kumar S, Rani P, Rana K, Rajput K, Jain D, Pal G, Aggarwal B, Pal S, Gupta SK, Kumar Y, Ramu VS, Bajaj A..  (2022)  Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid-Peptide Conjugates.,  65  (22.0): [PMID:36331380] [10.1021/acs.jmedchem.2c01293]

Source

Source(1):

• Scientific Literature